Similar articles

• A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.

  Joseph AP, Ward MR. Joseph AP, et al. Ann Emerg Med. 2000 Jul;36(1):1-9. doi: 10.1067/mem.2000.107655. Ann Emerg Med. 2000. PMID: 10874228 Clinical Trial.
• [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].

  Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM. Niu F, et al. Zhonghua Yi Xue Za Zhi. 2006 Jan 10;86(2):121-3. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16620720 Clinical Trial. Chinese.
• Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.

  Gillis AM, Verma A, Talajic M, Nattel S, Dorian P; CCS Atrial Fibrillation Guidelines Committee. Gillis AM, et al. Can J Cardiol. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001. Can J Cardiol. 2011. PMID: 21329862
• Amiodarone versus sotalol for atrial fibrillation.

  Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Raisch DW, Ezekowitz MD; Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Singh BN, et al. N Engl J Med. 2005 May 5;352(18):1861-72. doi: 10.1056/NEJMoa041705. N Engl J Med. 2005. PMID: 15872201 Clinical Trial.
• [Therapy of atrial fibrillation with class III anti-arrhythmia agents].

  Follath F, Candinas R, Frielingsdorf J. Follath F, et al. Herz. 1993 Feb;18(1):20-6. Herz. 1993. PMID: 8454249 Review. German.